Starting material collection & optimization 2022

Supply Chain

Starting material collection & optimization 2022

Starting material collection & optimization 2022

Filter by ContentType

Umbilical cord blood NK cells offer multiple advantages for cancer immunotherapy: lessons learned from Glycostem’s orphan drug oNKord®

Umbilical cord blood NK cells offer multiple advantages for cancer immunotherapy: lessons learned from Glycostem’s orphan drug oNKord®

Volker Huppert
14 January 2022
Expert Insight
 Navigating regulations to provide ethically sourced cellular material for research and development: UK perspective

Navigating regulations to provide ethically sourced cellular material for research and development: UK perspective

Salmah Ahmed
11 January 2022
Expert Insight
 Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing

Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing

Heidi Elmoazzen, PhD
11 January 2022
Interview
 Considerations for developing scalable and efficient collection network processes

Considerations for developing scalable and efficient collection network processes

Lacey Anderson, Sara Butler, Allison Montalvo
11 January 2022
Innovator Insight

Other editions


<< Back to Supply Chain channel